Coronavirus Supply Chain Threats Demand Coordinated Industry Response
Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.
You may also be interested in...
The Golden Winged Warbler And Creating Pharma Supply Chain Immunity
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
UK Firms Asked To Check Coronavirus Supply Chain Impact
Amid concerns that the coronavirus outbreak could have an impact on the supply of APIs and other materials sourced from Chinese manufacturers, pharmaceutical companies are to assess their supply chain situation to help ensure patients do not experience medicine shortages.
Novel Virus Brings Novel Threats To Global Pharmaceutical Manufacturing
As coronavirus spreads into China’s manufacturing region, quarantines and travel restrictions challenge international flow of pharmaceuticals, ingredients and personnel.